223 related articles for article (PubMed ID: 3814034)
1. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
Attias J; Gordon C; Ribak J; Binah O; Rolnick A
Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
[TBL] [Abstract][Full Text] [Related]
2. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
[TBL] [Abstract][Full Text] [Related]
3. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
[TBL] [Abstract][Full Text] [Related]
4. The Republic of Singapore Navy's Scopoderm TTS study: results after 2,200 man-days at sea.
How J; Lee PS; Seet LC; Tan PK
Aviat Space Environ Med; 1988 Jul; 59(7):646-50. PubMed ID: 3044323
[TBL] [Abstract][Full Text] [Related]
5. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
[TBL] [Abstract][Full Text] [Related]
6. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
Noy S; Shapira S; Zilbiger A; Ribak J
Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
[TBL] [Abstract][Full Text] [Related]
7. Transderm scopolamine efficacy related to time of application prior to the onset of motion.
Levy GD; Rapaport MH
Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
Pingree BJ; Pethybridge RJ
Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
[TBL] [Abstract][Full Text] [Related]
10. Safety of double-dose transdermal scopolamine.
Bar R; Gil A; Tal D
Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
[TBL] [Abstract][Full Text] [Related]
11. Scopolamine bioavailability in combined oral and transdermal delivery.
Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
[TBL] [Abstract][Full Text] [Related]
12. Transdermal scopolamine in the prevention of motion sickness at sea.
Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
14. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
Parrott AC
Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
[TBL] [Abstract][Full Text] [Related]
15. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
[TBL] [Abstract][Full Text] [Related]
16. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
Gil A; Nachum Z; Tal D; Shupak A
Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
[TBL] [Abstract][Full Text] [Related]
18. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
[TBL] [Abstract][Full Text] [Related]
19. Effect of transdermally administered scopolamine in preventing motion sickness.
McCauley ME; Royal JW; Shaw JE; Schmitt LG
Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
[TBL] [Abstract][Full Text] [Related]
20. The vestibulo-ocular reflex (VOR) under the influence of cinnarizine.
Doweck I; Gordon CR; Spitzer O; Melamed Y; Shupak A
J Vestib Res; 1994; 4(3):215-20. PubMed ID: 7921339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
